Back to RENAISSANCE TECHNOLOGIES LLC RENAISSANCE TECHNOLOGIES LLC

CORTCORT

Showing 8 of 28 quarters

Position history for RENAISSANCE TECHNOLOGIES LLCRENAISSANCE TECHNOLOGIES LLC's holdings in Corcept Therapeutics Incorporated.

Yes. Renaissance Technologies holds 5,261,628 shares of CORT (Corcept Therapeutics), worth $457.5M, as of its Q2 2026 13F filing. It reduced the position by 421,155 shares (-7.4%) from Q1 2026. Renaissance Technologies has held CORT in every 13F on record since Q3 2019, 28 quarterly filings. CORT is 0.6% of Renaissance Technologies' reported 13F portfolio.

Current Value

$457.5M

Current Shares

5.3M

Total Value Change

+$156.3M

Total Shares Change

-1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
5.3M
-7.4%
$457.5M0.6%$86.95
0
2026-Q1
Decreased
5.7M
-1.3%
$229.1M0.4%$40.31
0
2025-Q4
Decreased
5.8M
-5.4%
$200.4M0.3%$34.80
0
2025-Q3
Decreased
6.1M
-2.8%
$506.1M0.7%$83.11
0
2025-Q2
Increased
6.3M
+2.0%
$460M0.6%$73.40
45
2025-Q1
Decreased
6.1M
-0.9%
$701.7M1.1%$114.22
0
2024-Q4
Decreased
6.2M
-4.8%
$312.3M0.5%$50.39
0
2024-Q3
Decreased
6.5M
-5.8%
$301.2M0.5%$46.28
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used